A carregar...
Mineralocorticoid receptor antagonist use following heart failure hospitalization
AIMS: Patients hospitalized for heart failure (HF) are at increased risk for events post‐discharge. Mineralocorticoid receptor antagonists (MRAs) improve the clinical course of patients with HF with reduced ejection fraction. We assessed MRA use in high‐risk patients following an HF hospitalization...
Na minha lista:
| Publicado no: | ESC Heart Fail |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7160481/ https://ncbi.nlm.nih.gov/pubmed/32035000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12635 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|